210 related articles for article (PubMed ID: 17370595)
1. [Molecular target therapy for colonic neoplasms].
Oki E; Ota M; Honbo T; Egashira A; Tokunaga E; Sadanaga N; Morita M; Kakeji Y; Maehara Y
Nihon Naika Gakkai Zasshi; 2007 Feb; 96(2):289-94. PubMed ID: 17370595
[No Abstract] [Full Text] [Related]
2. [New developments in immunotherapy for digestive system diseases].
Imai K
Nihon Naika Gakkai Zasshi; 2005 Sep; 94(9):1901-7. PubMed ID: 16223155
[No Abstract] [Full Text] [Related]
3. Biological agents versus chemotherapy in the treatment of colorectal cancer.
Eng C; Shalan N
Expert Opin Pharmacother; 2006 Jul; 7(10):1251-71. PubMed ID: 16805714
[TBL] [Abstract][Full Text] [Related]
4. Technology evaluation: bevacizumab, Genentech/Roche.
Salgaller ML
Curr Opin Mol Ther; 2003 Dec; 5(6):657-67. PubMed ID: 14755893
[TBL] [Abstract][Full Text] [Related]
5. Accrual delayed in adjuvant bevacizumab trial.
Tuma RS
J Natl Cancer Inst; 2006 Apr; 98(7):439-40. PubMed ID: 16595779
[No Abstract] [Full Text] [Related]
6. Mixed news for Avastin.
Mack GS
Nat Biotechnol; 2009 Jun; 27(6):494. PubMed ID: 19513035
[No Abstract] [Full Text] [Related]
7. [Adjuvant bevacizumab and cetuximab for stage III colon cancer: why such failure in an adjuvant situation?].
André T; Larsen AK; de Gramont A
Bull Cancer; 2012 Jun; 99(6):607-8. PubMed ID: 22900267
[No Abstract] [Full Text] [Related]
8. Isolated brainstem involvement in posterior reversible leukoencephalopathy induced by bevacizumab.
El Maalouf G; Mitry E; Lacout A; Lièvre A; Rougier P
J Neurol; 2008 Feb; 255(2):295-6. PubMed ID: 18283405
[No Abstract] [Full Text] [Related]
9. Monoclonal antibodies in the treatment of advanced colorectal cancer.
Capdevila J; Saura C; Macarulla T; Casado E; Ramos FJ; Tabernero J
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S24-34. PubMed ID: 17981431
[TBL] [Abstract][Full Text] [Related]
10. [Angiogenesis inhibitors in cancer therapy. Bevacizumab against colon carcinoma].
Fieth C; Kebig A; Mohr K
Pharm Unserer Zeit; 2007; 36(6):442-5. PubMed ID: 17957688
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis of the jaw and bevacizumab therapy.
Van Poznak C
Breast Cancer Res Treat; 2010 Jul; 122(1):189-91. PubMed ID: 20464477
[No Abstract] [Full Text] [Related]
12. [A perspective: role of targeted therapy in colon cancer].
Chung HH; Jang BI
Korean J Gastroenterol; 2013 Mar; 61(3):128-35. PubMed ID: 23575231
[TBL] [Abstract][Full Text] [Related]
13. [Molecular-based treatment concepts in advanced pancreatic cancer].
Boeck S; Moosmann N; Stemmler HJ; Heinemann V
Dtsch Med Wochenschr; 2007 Apr; 132(15):818-22. PubMed ID: 17427093
[No Abstract] [Full Text] [Related]
14. Cardiovascular toxicity of new agents.
Maitland ML
Clin Adv Hematol Oncol; 2008 Sep; 6(9):657-9. PubMed ID: 18827788
[No Abstract] [Full Text] [Related]
15. Vascular endothelial growth factor inhibitors in colon cancer.
Díaz-Rubio E
Adv Exp Med Biol; 2006; 587():251-75. PubMed ID: 17163170
[TBL] [Abstract][Full Text] [Related]
16. Caution in adding bevacizumab in the adjuvant treatment of breast cancer.
Ziogas D; Roukos D
Ann Surg Oncol; 2010 Feb; 17(2):653-4; author reply 655-6. PubMed ID: 19888632
[No Abstract] [Full Text] [Related]
17. [Antibody treatment in colorectal cancer--what the surgeon needs to know].
Thalheimer A; Illert B; Reimer P; Bueter M; Thiede A; Gasser M; Fein M; Waaga-Gasser AM; Meyer D
Zentralbl Chir; 2008 Apr; 133(2):101-6. PubMed ID: 18415895
[TBL] [Abstract][Full Text] [Related]
18. Biological therapy update in colorectal cancer.
Sorscher SM
Expert Opin Biol Ther; 2007 Apr; 7(4):509-19. PubMed ID: 17373902
[TBL] [Abstract][Full Text] [Related]
19. Targeted agents for adjuvant therapy of colon cancer.
Saif MW
Clin Colorectal Cancer; 2006 May; 6(1):46-51. PubMed ID: 16796791
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor inhibitors in colorectal cancer: it's time to get back on target.
Meropol NJ
J Clin Oncol; 2005 Mar; 23(9):1791-3. PubMed ID: 15677698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
